Your browser doesn't support javascript.
loading
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
Watanabe, Kenichi; Niikura, Naoki; Kikawa, Yuichiro; Oba, Mari; Kobayashi, Kokoro; Tada, Hiroshi; Ozaki, Shinji; Toh, Uhi; Yamamoto, Yutaka; Tsuneizumi, Michiko; Okuno, Toshitaka; Iwakuma, Nobutaka; Takeshita, Takashi; Iwamoto, Takayuki; Ishiguro, Hiroshi; Masuda, Norikazu; Saji, Shigehira.
Afiliación
  • Watanabe K; Department of Breast Surgery, Hokkaido Cancer Center, Sapporo, Japan.
  • Niikura N; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan.
  • Kikawa Y; Department of Breast Surgery, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Oba M; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Kobayashi K; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Tada H; Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Ozaki S; Department of Gastrointestinal and Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Toh U; Department of Breast Surgery, Kurume University Hospital, Kurume, Japan.
  • Yamamoto Y; Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
  • Okuno T; Department of Breast Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Iwakuma N; Department of Breast Surgery, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Takeshita T; Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto, Japan.
  • Iwamoto T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
  • Ishiguro H; Breast Oncology Service, Saitama Medical University International Medical Center, Hidaka, Japan. ishiguro@saitama-med.ac.jp.
  • Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
Breast Cancer Res Treat ; 199(2): 253-263, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37000345
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Etiology_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Etiology_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Japón